enVVeno Medical (NVNO) Total Liabilities (2017 - 2026)

enVVeno Medical's Total Liabilities history runs 10 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 3.52% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 3.52% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, down 12.99% from the prior year.
• Total Liabilities eased to $2.4 million in Q1 2026 per NVNO's latest filing, from $2.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $3.5 million in Q2 2025 and bottomed at $2.3 million in Q1 2025.
• The 5-year median for Total Liabilities is $2.8 million (2024), against an average of $2.8 million.
• Across the five-year window, Total Liabilities jumped 149.08% in 2022 and fell 21.29% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $2.9 million in 2022, then decreased by 16.95% to $2.4 million in 2023, then advanced by 14.78% to $2.8 million in 2024, then declined by 12.99% to $2.4 million in 2025, then slipped by 3.37% to $2.4 million in 2026.
• Per Business Quant, the three latest NVNO Total Liabilities figures stand at $2.4 million (Q1 2026), $2.4 million (Q4 2025), and $2.9 million (Q3 2025).